In conclusion, GrB-expressing pDCs could have regulatory effects on tumor-specific T cells as well as cytotoxic potential toward virus-infected or transformed cells, implying a contribution to cancer progression or elimination, respectively. The gene discussed is GZMB; the disease is cancer.